Literature DB >> 22344274

Motifs for a deadly encounter.

Ken T Coppieters1, Matthias G von Herrath.   

Abstract

Entities:  

Mesh:

Year:  2012        PMID: 22344274      PMCID: PMC5679406          DOI: 10.1038/ni.2226

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


× No keyword cloud information.
  10 in total

1.  Four A6-TCR/peptide/HLA-A2 structures that generate very different T cell signals are nearly identical.

Authors:  Y H Ding; B M Baker; D N Garboczi; W E Biddison; D C Wiley
Journal:  Immunity       Date:  1999-07       Impact factor: 31.745

Review 2.  Microorganisms and autoimmunity: making the barren field fertile?

Authors:  Matthias G von Herrath; Robert S Fujinami; J Lindsay Whitton
Journal:  Nat Rev Microbiol       Date:  2003-11       Impact factor: 60.633

3.  CTLs are targeted to kill beta cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope.

Authors:  Ania Skowera; Richard J Ellis; Ruben Varela-Calviño; Sefina Arif; Guo Cai Huang; Cassie Van-Krinks; Anna Zaremba; Chloe Rackham; Jennifer S Allen; Timothy I M Tree; Min Zhao; Colin M Dayan; Andrew K Sewell; Wendy W Unger; Wendy Unger; Jan W Drijfhout; Ferry Ossendorp; Bart O Roep; Mark Peakman
Journal:  J Clin Invest       Date:  2008-10       Impact factor: 14.808

4.  Prevention of diabetes by manipulation of anti-IGRP autoimmunity: high efficiency of a low-affinity peptide.

Authors:  Bingye Han; Pau Serra; Abdelaziz Amrani; Jun Yamanouchi; Athanasius F M Marée; Leah Edelstein-Keshet; Pere Santamaria
Journal:  Nat Med       Date:  2005-05-22       Impact factor: 53.440

5.  Unconventional topology of self peptide-major histocompatibility complex binding by a human autoimmune T cell receptor.

Authors:  Michael Hahn; Melissa J Nicholson; Jason Pyrdol; Kai W Wucherpfennig
Journal:  Nat Immunol       Date:  2005-04-10       Impact factor: 25.606

6.  Structure of a human autoimmune TCR bound to a myelin basic protein self-peptide and a multiple sclerosis-associated MHC class II molecule.

Authors:  Yili Li; Yuping Huang; Jessica Lue; Jacqueline A Quandt; Roland Martin; Roy A Mariuzza
Journal:  EMBO J       Date:  2005-08-04       Impact factor: 11.598

7.  How virus induces a rapid or slow onset insulin-dependent diabetes mellitus in a transgenic model.

Authors:  M G von Herrath; J Dockter; M B Oldstone
Journal:  Immunity       Date:  1994-06       Impact factor: 31.745

8.  A highly tilted binding mode by a self-reactive T cell receptor results in altered engagement of peptide and MHC.

Authors:  Dhruv K Sethi; David A Schubert; Anne-Kathrin Anders; Annie Heroux; Daniel A Bonsor; Chantz P Thomas; Eric J Sundberg; Jason Pyrdol; Kai W Wucherpfennig
Journal:  J Exp Med       Date:  2011-01-03       Impact factor: 14.307

9.  Unique autoreactive T cells recognize insulin peptides generated within the islets of Langerhans in autoimmune diabetes.

Authors:  James F Mohan; Matteo G Levisetti; Boris Calderon; Jeremy W Herzog; Shirley J Petzold; Emil R Unanue
Journal:  Nat Immunol       Date:  2010-02-28       Impact factor: 25.606

10.  Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients.

Authors:  Ken T Coppieters; Francesco Dotta; Natalie Amirian; Peter D Campbell; Thomas W H Kay; Mark A Atkinson; Bart O Roep; Matthias G von Herrath
Journal:  J Exp Med       Date:  2012-01-02       Impact factor: 14.307

  10 in total
  2 in total

1.  Destruction of tissue, cells and organelles in type 1 diabetic rats presented at macromolecular resolution.

Authors:  Raimond B G Ravelli; Ruby D Kalicharan; M Cristina Avramut; Klaas A Sjollema; Joachim W Pronk; Freark Dijk; Abraham J Koster; Jeroen T J Visser; Frank G A Faas; Ben N G Giepmans
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

2.  Hotspot autoimmune T cell receptor binding underlies pathogen and insulin peptide cross-reactivity.

Authors:  David K Cole; Anna M Bulek; Garry Dolton; Andrea J Schauenberg; Barbara Szomolay; William Rittase; Andrew Trimby; Prithiviraj Jothikumar; Anna Fuller; Ania Skowera; Jamie Rossjohn; Cheng Zhu; John J Miles; Mark Peakman; Linda Wooldridge; Pierre J Rizkallah; Andrew K Sewell
Journal:  J Clin Invest       Date:  2016-05-16       Impact factor: 14.808

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.